- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Lai, C.-Y.
- Articles by Jazwinski, S. M.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Lai, C.-Y.
- Articles by Jazwinski, S. M.
A Mutation in the ATP2 Gene Abrogates the Age Asymmetry Between Mother and Daughter Cells of the Yeast Saccharomyces cerevisiae
Chi-Yung Laia, Ewa Jarugaa, Corina Borghoutsa, and S. Michal Jazwinskiaa Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112
Corresponding author: S. Michal Jazwinski, Louisiana State University Health Sciences Center, 1901 Perdido St., Box P7-2, New Orleans, LA 70112., sjazwi{at}lsuhsc.edu (E-mail)
Communicating editor: M. JOHNSTON
| ABSTRACT |
|---|
The yeast Saccharomyces cerevisiae reproduces by asymmetric cell division, or budding. In each cell division, the daughter cell is usually smaller and younger than the mother cell, as defined by the number of divisions it can potentially complete before it dies. Although individual yeast cells have a limited life span, this age asymmetry between mother and daughter ensures that the yeast strain remains immortal. To understand the mechanisms underlying age asymmetry, we have isolated temperature-sensitive mutants that have limited growth capacity. One of these clonal-senescence mutants was in ATP2, the gene encoding the ß-subunit of mitochondrial F1, F0-ATPase. A point mutation in this gene caused a valine-to-isoleucine substitution at the ninetieth amino acid of the mature polypeptide. This mutation did not affect the growth rate on a nonfermentable carbon source. Life-span determinations following temperature shift-down showed that the clonal-senescence phenotype results from a loss of age asymmetry at 36°, such that daughters are born old. It was characterized by a loss of mitochondrial membrane potential followed by the lack of proper segregation of active mitochondria to daughter cells. This was associated with a change in mitochondrial morphology and distribution in the mother cell and ultimately resulted in the generation of cells totally lacking mitochondria. The results indicate that segregation of active mitochondria to daughter cells is important for maintenance of age asymmetry and raise the possibility that mitochondrial dysfunction may be a normal cause of aging. The finding that dysfunctional mitochondria accumulated in yeasts as they aged and the propensity for old mother cells to produce daughters depleted of active mitochondria lend support to this notion. We propose, more generally, that age asymmetry depends on partition of active and undamaged cellular components to the progeny and that this "filter" breaks down with age.
AGING is characterized by the progressive loss of functional and structural integrity of the organism. This process can be seen in most multicellular and in some unicellular organisms such as the budding yeast Saccharomyces cerevisiae (![]()
![]()
![]()
![]()
Life-span mutants include those with extended as well as those with shortened life spans. Mutants with shortened life spans are frequently encountered. However, the conclusions from analyses of these mutants can be misleading, because any deleterious genetic change can truncate life span whether or not it is associated with normal aging. The isolation of mutants on the basis of extended life span is technically more difficult, and examples of such studies have been rare (![]()
![]()
![]()
Some of the key questions in aging concern the differences between germline and soma. Any mechanism invoked to explain the aging of the soma must also be able to accommodate the immortality of the germline. At the level of the organism, the issue is the renewal that occurs at each generation, providing the progeny a fresh start with the potential for a full life span. The aging process of yeast cells best illustrates the cellular and generational asymmetry mentioned above. A daughter cell, or bud, is produced from the mother cell in each cell division cycle. In this asymmetric cell division, the mother cell represents the soma and the daughter cell the germline. Individual cells are mortal and can divide only a limited number of times (![]()
![]()
![]()
![]()
![]()
![]()
We decided to isolate and characterize yeast clonal-senescence mutants to gain a better understanding of the establishment of age asymmetry in yeast cell division. Such mutants are also likely to provide clues about the mechanisms of aging. In this article, we report the isolation and characterization of a temperature-sensitive age-asymmetry mutant and identification of the mutated gene. We also examine the cellular mechanism underlying the loss of age asymmetry and clonal senescence, and we provide evidence for the involvement of this mechanism in normal aging.
| MATERIALS AND METHODS |
|---|
Strains and growth media:
S. cerevisiae strain YPK9 (MATa ade2-101ochre his3-
200 leu2-
1 lys2-801amber trp1-
63 ura3-52) used for mutant isolation has been described (![]()
0 petite in YPK9 to generate strain YSK365 have also been described (![]()
![]()
Isolation of clonal-senescence mutants:
To isolate mutants with a clonal-senescence phenotype, a logarithmic-phase yeast culture of the wild-type strain YPK9 was mutagenized with ethyl methanesulfonate (EMS) to achieve a kill ratio of
40%, using procedures described by ![]()
The small size of the selected colonies could be caused by either reduced growth rates or limited replicative capacity at 37°. To distinguish between these two possibilities, isolates were tested by repetitive passaging (serial streaking) at 37°. Cells were streaked on YPD plates and incubated at 37° for 48 hr. From the streaks that grew, cells were streaked onto the next plate or sector. This serial streaking continued with 48 hr of incubation elapsing between each consecutive passage. Isolates that stopped dividing at any point between the first and fifth streaking were considered clonal-senescence mutants and were saved. Only 2 of the initial 200 isolates passed the serial-streaking test. At 37°, isolates CS8 and CS16 had a clonal life span of
70 and 40 hr, respectively. We chose CS16 for further analysis because of its more drastic phenotype. The remaining isolates were mutants that had reduced growth rates at 37°. These mutants did not stop growing after repeated passages. Cell division cycle mutants would not form detectable colonies at 37° in the mutant isolation scheme and thus did not enter into the analysis.
Life-span determination:
Procedures for life-span determination were modified from ![]()
- genotype has been shown to alter yeast life span (![]()
- cells. To set up a life-span determination experiment, one drop of cells from each strain was placed on the edge of a freshly made YPD plate. Individual cells were pulled out of the drop and positioned separately from each other. After 23 hr of incubation, virgin daughter cells produced by these cells were moved to the center of the plates and lined up in rows. To measure the life spans of these virgin cells, their buds were removed successively and discarded to the edge of the plate with a micromanipulator. The number of buds produced by each cell was recorded. Each experiment included 3050 cells of each strain. Survival curves were plotted and the significance of differences between life spans of strains was analyzed using the Mann-Whitney test.
Plasmid complementation:
A yeast genomic DNA library in plasmid YCp50 (![]()
Plasmid gap repair and DNA sequencing:
One of the plasmids that complemented mutant CS16 was used for plasmid gap repair. This plasmid YP5-SCS1 carries a 10.5-kb insert, containing the entire ATP2 gene. This plasmid was cut with BamHI to create a 4243-bp gap from 1388 bp upstream to 2855 bp downstream of the translation start site of ATP2. CS16 cells were transformed with this gapped plasmid and selected on CM-uracil plates. Plasmids were isolated from Ura+ colonies and examined by restriction analysis. Those that contained a full-size insert were introduced back into CS16 cells and tested for their ability to complement the clonal-senescence phenotype. Two of the plasmids that failed to complement were purified, and their sequences from the ATP2-coding and 150-bp upstream regions were determined, using the Thermo Sequenase kit (Amersham Life Science).
Gene deletion:
Deletion of ATP2 was achieved by
-transformation (![]()
![]()
Telomere analysis:
Telomere length was determined by examination of terminal restriction fragments of XY' telomeres generated by digestion with XhoI, essentially according to ![]()
Analysis of extrachromosomal ribosomal DNA circles (ERCs):
ERCs were detected by Southern blot analysis of total genomic DNA, using a 2-kb fragment of the 35S rRNA gene as a probe, essentially as described (![]()
-32P]dCTP using the RediPrime II labeling system (Amersham Biosciences) and purified on NICK columns (Amersham Biosciences). The DNA on the membrane was first hybridized with the actin probe for normalization, followed by the rDNA probe. The membrane was washed two times for 15 min in 2x SSC, 0.5% SDS at 42° and then two times for 15 min in 0.1x SSC, 0.2% SDS at 60°. The membrane was analyzed in a phosphorimager (Molecular Dynamics, Sunnyvale, CA), using ImageQuaNT software.
Flow cytometry:
Mitochondrial membrane potential was determined in individual cells using 5,5',6,6'-tetrachloro-1,1,3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1; Molecular Probes, Eugene, OR), a cationic dye that exhibits potential-dependent accumulation in mitochondria (![]()
ex = 490 nm,
em = 527 nm). Mitochondrial mass was estimated using nonyl acridine orange (NAO; Molecular Probes), which binds cardiolipin regardless of mitochondrial energy state (
ex = 490 nm,
em = 518 nm; ![]()
ex = 365 nm,
em = 435 nm; ![]()
Exponentially growing cells (12 x 107/ml) were incubated in the dark with JC-1 (5 µg/ml) or NAO (1 µg/ml) for 20 min in YPD supplemented with 120 µg/ml adenine at either permissive or restrictive temperature. Cells growing on solid medium were scraped off the plates and resuspended in the YPD medium and stained in the same manner. In some cases, the cells were washed with sterile water and stained for an additional 5 min with freshly prepared Calcofluor White M2R (0.1 mg/ml) in the dark at room temperature. The cells were then washed and sonicated for 3 sec prior to flow cytometry. Flow cytometry was carried out using the fluorescence-activated cell sorter Vantage SE (Becton-Dickinson) and the Enterprise II coherent UV laser (351364 nm) and Argon laser (488 nm). Fluorescence was detected in the following channels: FL-1 (530/30 nm), FL-2 (585/42 nm), and FL-5 (424/44 nm).
Fluorescence microscopy:
Mitochondria were stained in living cells (2 x 107/ml) growing exponentially in YPD supplemented with 120 µg/ml adenine by incubation with 80 nM Mitotracker Red (Molecular Probes) for 15 min in the dark at permissive or restrictive temperature. Cells were washed twice with sterile water, sonicated for 3 sec, placed on a slide freshly precoated with concanavalin A (Sigma), and immediately analyzed using a Nikon Microphot-SA epifluorescence microscope with a x63 objective. Images were captured with a Micromax CCD camera model ASI 10014 (Princeton Instruments) and analyzed with MetaMorph 4.5 universal imaging software (Advanced Scientific).
Immunofluorescence microscopy:
Cells were cultured to late logarithmic phase in YPD at 30° overnight. Portions of the cultures were incubated for 4 hr at 37° or diluted 400-fold in 5 ml YPD and cultured for 24 hr at 37°. Parts of these 24-hr cultures were diluted 40-fold in 5 ml YPD and incubated for an additional 24 hr at 37° to provide the 48-hr samples. All cultures were harvested in late logarithmic phase. Parallel cultures were handled as above, but the temperature was maintained at 30°. The cells from these cultures were immediately processed for indirect immunofluorescence, as described below, and examined using the Nikon Microphot-SA epifluorescence microscope and imaging system described above.
For confocal microscopy, cells were grown on solid YPD medium at 30° or 37° with serial streaking, as described earlier. These cells were scraped from the solid medium and resuspended in 5 ml of YPD for immediate processing for indirect immunofluorescence. The cells were visualized in a Nikon TE300 microscope equipped with a Bioradiance 2100 laser scanning system with a 10-MW krypton/argon laser (Bio-Rad, Hercules, CA), which was operated by LaserSharp 2000 confocal software (Bio-Rad). A total of 200 sections of 0.05 µm each was taken for a 10-µm scanned slice with an optical magnification of x1000, using a x100 objective. The final magnification of the cells was x1500, using a digital zoom of x1.5.
Cells were fixed by adding 650 µl of 37% formaldehyde (Sigma) and 650 µl of 1 M potassium phosphate (pH 6.5) to 5 ml of yeast culture in YPD. The cells were incubated on a shaker for 2 hr at either 30° or 37°, corresponding to the temperature at which they had been cultured. They were washed two times with 0.1 M potassium phosphate (pH 6.5) and two times with the same buffer containing 1.2 M sorbitol (KPBS). The cells were suspended in 500 µl of KPBS and 2.5 µl of 2-mercaptoethanol and 15 µl Zymolyase 100T (10 mg/ml, U.S. Biologicals) were added. The suspension was incubated at 30° for 3045 min to digest the cell wall. The cells were then washed two times with KPBS and suspended in 100500 µl of KPBS, according to the size of the cell pellet. The cell suspension (20 µl) was deposited on a poly-lysine-coated slide (ICN Biomedicals) and left for 10 min. The fluid was removed by aspiration, and the slide was placed in methanol at -20° for 6 min. Then the slide was placed in ice-cold acetone for 30 sec. The slide was briefly air dried and washed 10 times with PBS (1.4 M NaCl, 30 mM KCl, 80 mM Na2HPO4, 30 mM KH2PO4, pH 7.3). The cells were blocked with PBS-BSA [2 mg bovine serum albumin (BSA)/ml PBS] for 30 min. Porin staining was performed by incubating the slides in a 1:20 dilution of mouse antiporin antibodies (Molecular Probes) in PBS-BSA for 1 hr at room temperature. Slides were washed 10 times with PBS-BSA and then incubated with a fluorescein isothiocyanate-coupled secondary antibody (goat anti-mouse, Molecular Probes) at 1:32 dilution for 2 hr. Slides were washed 10 times as above and mounted in ProLong Antifade (Molecular Probes).
| RESULTS |
|---|
Clonal senescence results from loss of age asymmetry in CS16:
Clonal senescence mutants were isolated as described in MATERIALS AND METHODS, and one of them was chosen for further characterization. The mutant CS16 displayed clonal senescence at the restrictive temperature. Fig 1 shows the results of serial streaking of the clonal-senescence mutant CS16 and the parental strain YPK9 at permissive and restrictive temperatures. CS16 growth was severely retarded by the third passage at 37°, while the wild type could be restreaked numerous times. At 30°, there was no evidence of clonal senescence on serial streaking for either CS16 or the parental strain YPK9.
|
Clonal senescence can result from a disruption of the age asymmetry between mother and daughter, such that daughters are not born with the potential for a full life span. It can also be caused by defects in the synthesis of essential cellular components or metabolites. The gradual dilution of these cellular ingredients through continuous cell divisions would eventually result in growth arrest of mothers and daughters equally. To distinguish between mutants of age asymmetry and such mutants of synthesis, a modified life-span determination experiment was performed. Virgin yeast cells produced at 30° were moved to 36° and allowed to divide seven times on average. The first six buds produced by these mother cells were removed and discarded by micromanipulation. The seventh buds and their mother cells were then moved back to 30°, and their remaining life spans at 30° were determined. In a mutant of synthesis, growth arrest results from disruption of specific synthetic activity. Upon temperature shift-down, the disrupted synthetic activity recovers and both mother and daughter cells resume normal growth. Since daughter cells are younger than mother cells, they should enjoy a longer mean life span than the mother cells' remaining life span (Fig 2A, bottom). Mutants of age asymmetry, on the other hand, produce daughter and mother cells of the same age at the restrictive temperature. Their ages remain the same, and thus they should have the same remaining life spans after the temperature shift-down (Fig 2A, top). Results from an experiment to distinguish mutants of age asymmetry from mutants of synthesis are shown in Fig 2B and Fig C. While wild-type daughter cells produced at 36° outlived their mother cells by more than four generations (P < 0.00015), those of the CS16 mutant had a mean life span statistically identical to the remaining life span of their mother cells (P = 0.70). Therefore, we conclude that CS16 is a mutant of age asymmetry.
|
Isolation of the gene mutated in CS16:
Genetic analysis of the CS16 mutant showed that its clonal-senescence phenotype is the result of a single, semidominant mutation. A wild-type x CS16 heterozygous strain can grow indefinitely at 36° but produces smaller colonies than those of the corresponding wild type. We cloned the wild-type allele of CS16 by complementation for production of large colonies at restrictive temperature. We isolated 10 independent plasmid clones in this screen. All of these plasmids carried DNA inserts from the same region of yeast chromosome X. Deletion analysis narrowed the region to a single gene, ATP2.
Linkage analysis confirmed that ATP2 is closely linked to the CS16 mutation. Strain CS16 was mated with a MAT
strain isogenic to YPK9, its parental strain. The resulting diploid strain was sporulated. The clonal-senescence phenotype segregated 2:2 in all tetrads analyzed. One of the MAT
segregants that displayed the clonal-senescence phenotype was isolated and designated CS16
. A URA3 marker was inserted 400 bp downstream from the ATP2 gene of YPK9, between this gene and the neighboring gene CAF17, by single-step insertion to produce strain YCL35. This strain was mated with CS16
. The diploid strain obtained this way was sporulated. Twenty tetrads were dissected and analyzed, and they all contained two Ura- spores that showed the clonal-senescence phenotype at 36° and two Ura+ spores that produced normal colonies at 36°.
A deletion of ATP2 was generated in strain YPK9. The atp2
strains failed to grow on nonfermentable carbon sources such as glycerol, as expected. These strains also failed to grow under anaerobic conditions. However, on 2% glucose media, growth and cell morphology of these strains appeared normal at 30°. At 37°, the atp2
strains displayed the clonal-senescence phenotype similar to CS16 on serial streaking (Fig 1). However, the phenotype was more severe. The end-point colony sizes were usually smaller than that of CS16, and a dramatic reduction in the number of colonies occurred one or two sectors earlier. In contrast to the severe clonal-senescence phenotype of atp2
strains, other nuclear petites (cox4
), as well as mitochondrial petites (
0), did not display any sign of clonal senescence (Fig 1).
Deletion of ATP2 in strain W303-1A also resulted in a clonal-senescence phenotype, which manifested itself at 37°. Interestingly, however, this was observed only on YPR growth medium, in which glucose repression does not operate. This suggests that glucose derepression is a permissive factor for clonal senescence.
Identification of the atp2 mutation in CS16:
The atp2 allele of CS16 was retrieved by plasmid gap repair. A total of 10 independent plasmids were isolated. These plasmids were purified from E. coli, introduced back into CS16, and tested for their ability to complement the clonal-senescence phenotype. Nine of these plasmids did not complement, suggesting that they carry the mutant allele. The atp2 gene from 2 of these plasmids was sequenced (Fig 3A). In each case, only one identical base change was found. The G was replaced by an A at nucleotide 325, causing a valine-to-isoleucine substitution at the ninetieth amino acid of the mature polypeptide (amino acid 109 of the precursor). This valine is a very conserved residue, located in a conserved domain. Fig 3B shows sequences of the region adjacent to this residue from several species. Valine is present in most species. Except for the presence of alanine in a few species, no other amino acid has been found at this position. However, the function of this region remains obscure, because it has not been implicated in nucleotide binding or enzyme activity (![]()
![]()
![]()
|
Growth characteristics of CS16 cultures:
ATP2 belongs to the class of mitochondrial genome integrity genes, which affect mitochondrial DNA stability (![]()
![]()
![]()
![]()
![]()
We compared the growth rates of CS16 and its parental strain YPK9 at 30° on YPD (glucose) and found them to be indistinguishable (112-min doubling time). There was also no significant difference between the two strains grown on YPG (glycerol) at either 30° (173 and 156 min for YPK9 and CS16, respectively) or 37° (216 and 218 min, respectively), although growth was slower at the elevated temperature. Combination of CS16 with a
- background markedly diminished growth rate (285-min doubling time) compared to a
- YPK9 (146-min doubling time) on YPD at 30°.
The CS16 mutant did not appear to accumulate petites excessively at either 30° or 37°, as compared to YPK9 (Fig 4). Indeed, the frequency of petites in CS16 cultures is much lower and begins to equal that found in YPK9 only upon prolonged culture at 37°. However, the viability of CS16 declined at 37°, becoming significantly lower than that of its parental strain YPK9 after 48 hr. This loss of viability was associated with clonal senescence (Fig 1). The temperature sensitivity of the clonal-senescence phenotype in the CS16 point mutant is apparently not due to a temperature-sensitive mutation in the F1-ATPase itself, because atp2
mutants also show thermo-sensitive clonal senescence.
|
Telomere attrition and ERC accumulation are not the cause of clonal senescence in atp2 mutants:
It is known that induction of telomere shortening leads to the extinction of yeast clones similar to a senescent phenotype (![]()
strain could be telomere attrition (Fig 5A). There was no evidence for a change in the electrophoretic mobility of the terminal restriction fragments of XY' telomeres at restrictive temperature, even after four serial streakings. Clonal senescence had resulted in a dramatic reduction in cell viability in these strains at this time, as compared to the wild-type parent (Fig 1 and Fig 4).
|
It has been shown that the accumulation of ERCs, a process that usually occurs during the yeast replicative life span, can kill yeast (![]()
strain. There was little, if any, change in the intracellular ERC content of cells, even after clonal senescence was very pronounced (Fig 5D). Thus, ERC accumulation is not the cause of clonal senescence.
Effect of mutation in ATP2 on mitochondrial membrane potential (
):
Yeast cells grown on nonfermentable carbon sources derive energy primarily through the synthesis of ATP by ATP synthase, which is driven by the activity of the electron transport chain (![]()

that provides energy for the transport of metabolites across the inner mitochondrial membrane. In the absence of a functional respiratory chain, cells reverse the activity of ATP synthase, using ATP to establish 
(![]()

. Yeast may also establish 
by a third mechanism involving the ADP/ATP translocator (![]()

.
We examined the 
of CS16 cells undergoing progressive clonal senescence by flow cytometry (Fig 6, AD). At 37°, there was a shift of the cell population to higher 
values for both CS16 and the YPK9 control, as visualized by the JC-1 stain. However, a new population of CS16 cells with a low 
appeared at this temperature, and this population progressively increased in number as clonal senescence became more and more extensive. The shift to higher 
values coincided with an increase in mitochondrial mass, as evidenced by NAO staining (Fig 6, EH). The population of CS16 cells exhibiting low 
was associated with a decline in mitochondrial mass. However, this loss of mitochondrial mass was delayed compared to the loss of 
. The rates of decline of 
and mitochondrial mass are quantified in Fig 6I and Fig J. Double staining with JC-1 and Calcofluor revealed that the population of CS16 cells with low 
contained primarily young cells with few or no bud scars (Fig 6K and Fig L). It is possible to estimate the extent of mitochondrial depletion in CS16 at 37° from the flow cytometry following NAO staining. There was an average decrease in mitochondrial mass of
40-fold (Fig 6H) in 50% of the cells (Fig 6J).
|
Morphology and segregation of mitochondria in the atp2 mutant:
The collapse of 
and loss of mitochondria in CS16 indicated by the flow-cytometric analysis prompted us to examine mitochondria in these cells by microscopy. The morphology and distribution of mitochondria in the cells was visualized in a confocal microscope after staining for the outer membrane protein porin. Mitochondria in CS16 at 30° and YPK9 at 30° and 37° (Fig 7) displayed the normal tubular morphology and permeated the entire cell volume. In CS16 at 37° (Fig 7), the mitochondria appeared punctate and tended to form one or a few large aggregates with progressive clonal senescence.
|
The results obtained with the confocal microscope were confirmed by fluorescence microscopy (Fig 8). We found, furthermore, that unlike the wild-type, parental strain YPK9 incubated at 37°, CS16 undergoing clonal senescence at 37° frequently segregated few or no mitochondria to daughters (buds). As clonal senescence progressed (Fig 8, 37° for 48 hr), many of the CS16 cells became devoid of mitochondria, as determined by staining for porin. This result was confirmed by staining with NAO for mitochondrial membrane and 4',6-diamidino-2-phenylindole for mitochondrial DNA (not shown).
|
To further examine the series of events in CS16, functional mitochondria were visualized in viable cells by staining with Mitotracker Red, which requires membrane potential for uptake (Fig 9). As with porin staining, a defect in segregation of active mitochondria to buds was apparent, as was a progressive loss of visible mitochondria in general, with increasing clonal senescence (Fig 9D and Fig F). However, these cellular deficits in functional mitochondria preceded the same events as observed by porin staining for mitochondrial mass (Fig 8). These results are consistent with those obtained by flow cytometry, which showed that a collapse in 
precedes the loss of mitochondrial mass (Fig 6).
|
Effect of aging on mitochondria:
The loss of 
appears to result in the lack of proper segregation of mitochondria, followed by mitochondrial loss leading to clonal senescence. Could this train of events be involved in normal yeast aging? We examined 
as a function of replicative age by flow cytometry after staining with JC-1 and Calcofluor (Fig 10). Clearly, there was an increase in 
as a function of age, as depicted by the linear approximation of the dependence of 
on bud scar number. However, there was an even greater increase in mitochondrial mass with age, as evidenced by staining with NAO and Calcofluor. This increase was about fivefold greater than the increase in 
, as judged by the slopes of the linear approximations. This indicates a fivefold decline in 
with replicative age. Thus, mitochondrial dysfunction accumulates during the replicative life span.
|
Young and old yeast cells were prepared by fluorescence-activated cell sorting after staining with Calcofluor. We determined the propensity of the sorted cells to produce daughters with low 
. Older cells had a tendency to have daughters with low relative 
(Fig 11C), as a consequence of segregating mitochondria deficient in 
(Fig 11B) rather than as a consequence of a difference in mitochondrial mass partitioned (Fig 11A). Thus, events similar to those induced in atp2 mutants that result in loss of age asymmetry and clonal senescence also occur as a consequence of normal replicative aging in yeast.
|
| DISCUSSION |
|---|
We have developed an isolation scheme for age-asymmetry mutants in yeast that display clonal senescence (Fig 1). Two distinct mutants were isolated, one of which has been characterized in detail. This mutant, CS16, has a point mutation in the ATP2 gene (Fig 3), which encodes the ß-subunit of the mitochondrial F1-ATPase. This mutation disrupts the age asymmetry between mother and daughter yeast cells (Fig 2). Similar, although more drastic, effects are observed in an atp2
strain (Fig 1). The CS16 mutant is indistinguishable from the wild-type YPK9 in its growth rate on both fermentable and nonfermentable carbon sources. Elimination of mitochondrial DNA was needed in conjunction with CS16 (or atp2
) to reduce growth rate, and it did so drastically. CS16 did not accumulate petites in comparison with YPK9. However, it suffered a progressive and extensive loss of viability on both solid and liquid media at the restrictive temperature (Fig 4), which was associated with clonal senescence (Fig 1). This loss of viability appeared to result from a loss of mitochondrial mass and not simply from a loss of mitochondrial function (Fig 6, Fig 8, and Fig 9). The expression of the clonal-senescence phenotype was under glucose repression.
Mutations in ATP2 do not induce telomere attrition nor do they result in the accumulation of ERCs to cause clonal senescence (Fig 5). However, they do lead to the loss of 
, which precedes the loss of mitochondrial mass during clonal senescence (Fig 6, Fig 8, and Fig 9). The cells that have lost mitochondria are primarily young cells. The loss of 
coincides with changes in the morphology and intracellular distribution of mitochondria (Fig 7), and this is accompanied by lack of segregation of normal numbers of mitochondria to daughter cells (Fig 8 and Fig 9). The loss of 
found in clonal senescence also occurs as a consequence of normal aging in yeast (Fig 10), and old yeast have a tendency to segregate inactive mitochondria to their daughters (Fig 11).
Our results indicate that proper segregation of mitochondria is important in the establishment of age asymmetry between mothers and daughters. They also implicate 
in this process. The clonal senescence induced by mutations in ATP2 appears to result from the mitochondrial dysfunction that they precipitate. Similar mitochondrial dysfunction and loss of age asymmetry occurs normally during yeast aging. We propose the following model to explain these findings (Fig 12). Mitochondrial dysfunction increases with age in yeast, as it does in mammalian cells (![]()
![]()
![]()
![]()
|
Clonal senescence mutants have been isolated previously. The induction of telomere shortening leads to clonal senescence in yeast (![]()
![]()
By comparing the generation times of daughter cells produced by mother cells of different ages, ![]()
![]()
![]()
![]()
![]()
The evolutionary theory of aging has pointed out that aging has multiple causes. Therefore, the establishment of age asymmetry is also likely to depend upon numerous mechanisms and structures. A logical step in identifying elements essential for age asymmetry is to isolate mutants with defects in maintenance of age asymmetry. We initiated a genetic screen for age-asymmetry mutants by looking for strains that display a clonal-senescence phenotype. We anticipated a requirement for "filtering" of damaged constituents from daughter cells as essential for establishment of heritable age asymmetry (![]()
![]()
Mother-daughter asymmetry has been the subject of analysis in yeast, since ![]()
![]()
The primary function of F1, F0-ATPase in yeast is ATP synthesis. However, our results suggest that this enzyme is also involved in establishing age asymmetry. The F1, F0-ATPase clearly has functions independent of the ATP-synthesizing activity. One of these functions is required for optimal growth of
- cells or
+ cells under anaerobic conditions, where oxidative phosphorylation does not take place. The role of F1, F0-ATPase in these conditions is possibly maintenance of a proper 
. In human cells, 
can be maintained by a functioning electron transport chain, the ATP-dependent proton pumping activity of F1, F0-ATPase, or the electrogenic ADP/ATP exchange activity of mitochondrial ADP/ATP translocator enzymes (![]()
![]()
![]()
![]()

(cox4
) or electron transport and F1, F0-ATPase proton pumping (
0) does not result in clonal senescence (Fig 1). The clonal-senescence phenotype is observed only on fermentable carbon sources, a condition in which the electron transport chain is not very active (![]()

, a function that may be suboptimal in CS16. Perhaps the ADP/ATP translocator also cannot suffice without a fully active F1-ATPase. It will be interesting to determine whether mutations in the translocator are synthetic to atp2.
The delayed effects of CS16 or atp2
may be explained by postulating the gradual accumulation of cellular damage, in particular to mitochondria, which exhibit progressive functional decline manifested in loss of 
. These events could play out at the molecular level in several ways. Atp2p is important not only for assembly of the ATP synthase itself but also for assembly of protein complexes of the electron transport chain, as indicated earlier. Thus, alterations in Atp2p could disrupt mitochondrial stability. In similar fashion, Atp2p might affect the assembly of the protein complexes that are involved in mitochondrial distribution and inheritance, either directly or through 
. These are only examples of the possibilities.
The studies we have described may have implications for human aging. Mitochondrial dysfunction is associated with aging in humans (![]()
| ACKNOWLEDGMENTS |
|---|
The skillful help of Luis Marrero with confocal microscopy and Phil Constantin with fluorescence microscopy is greatly appreciated. This work was supported by grants from the National Institute on Aging of the National Institutes of Health (U.S.P.H.S.) and by a gift from Heinz Keller of Tasmania.
Manuscript received January 2, 2002; Accepted for publication June 24, 2002.
| LITERATURE CITED |
|---|
ABRAHAMS, J. P., A. R. LESLIE, R. LUTTER, and J. E. WALKER, 1994 Structure at 2.8 Å resolution of F1-ATPase from bovine heart mitochondria. Nature 370:621-628.[Medline]
ARNHEIM, N. and G. CORTOPASSI, 1992 Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat. Res. 275:157-167.[Medline]
ASCHENBRENNER, M., D. M. MUELLER, R. ZAK, and R. J. WIESNER, 1993 Increased expression of F1-ATP synthase subunits in yeast strains carrying point mutations which destabilize the ß subunit. FEBS Lett. 323:27-30.[Medline]
AUSUBEL, F. M., R. BRENT, R. E. KINGSTON, D. D. MOORE, D. D. SEIDMAN et al., 1994 Current Protocols in Molecular Biology. Green Publishing Associates/Wiley-Interscience, New York.
BAKHTIARI, N., J. LAI-ZHANG, B. YAO, and D. M. MUELLER, 1999 Structure/function of the ß-barrel domain of F1-ATPase in the yeast Saccharomyces cerevisiae.. J. Biol. Chem. 273:16363-16369.
BENEL, L., X. RONOT, J. C. MOUNOLOU, F. GAUDEMER, and M. ADOLPHE, 1989 Compared flow cytometric analysis of mitochondria using 10-n-nonyl acridine orange and rhodamine 123. Basic Appl. Histochem. 33:71-80.[Medline]
BODNAR, A. G., M. OUELLETTE, M. FROLKIS, S. E. HOLT, and C. P. CHIU et al., 1998 Extension of life-span by introduction of telomerase into normal cells. Science 279:349-352.
BOYER, P. D., 1997 The ATP synthasea splendid molecular machine. Annu. Rev. Biochem. 66:717-749.[Medline]
BUCHET, K. and C. GODINOT, 1998 Functional F1-ATPase essential in maintaining growth and membrane potential of human mitochondrial DNA-depleted
0 cells. J. Biol. Chem. 273:22983-22989.
CHEN, X. J. and G. D. CLARK-WALKER, 1996 The mitochondrial genome integrity gene, MGI1, of Kluyveromyces lactis encodes the ß-subunit of F1-ATPase. Genetics 144:1445-1454.[Abstract]
CONRAD-WEBB, H. and R. A. BUTOW, 1995 A polymerase switch in the synthesis of rRNA in Saccharomyces cerevisiae.. Mol. Cell. Biol. 15:2420-2428.[Abstract]











